PHARMACY

Bell and Howell unveils QuickRx automated prescription pickup solution

Bell and Howell's QuickRx automates the prescription pickup process, freeing pharmacy staff to assist customers.
Zydus Cadila gets tentative FDA approval for generic Janumet XR

Zydus Cadila's generic Janumet will give Type 2 diabetes patients another treatment option.
Novartis changes Sandoz leadership

Francesco Balestrieri has been named as interim CEO of Sandoz as Richard Francis steps down as Sandoz CEO.
Adlon Therapeutics gets FDA green light for Adhansia XR capsules

Adlon Therapeutics' Adhansia XR capsules offer a new option for ADHD patients.
Alkem gets FDA nod for generic Diovan

Alkem's generic Diovan is expected to help relieve a recent shortage of valsartan.
FDA approves new indication for Regeneron, Sanofi’s Dupixent

The FDA has approved a new indication for Dupixent, providing an option for patients age 12-to-17 years old with moderate to severe atopic dermatitis.
Cynthia Schwalm to join Hikma's board

Cynthia Schwalm, who has held positions at Ipsen, Eisai, Amgen and J&J, is joining Hikma's board June 1.
Lannett to distribute generic Adderall

Adderall, including generic versions, had a market value of about $361 million for the 12 months ended January 2019, Lannett said.